| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Hill Kathryn | Director | C/O CELANESE CORPORATION, 222 W. LAS COLINAS BLVD., SUITE 900N, IRVING | /s/ Christine Dryden, Attorney-in-Fact for Kathryn Hill | 30 Jan 2026 | 0001533931 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CE | Common Stock | Conversion of derivative security | $0 | +1,808 | +12% | $0.000000 | 16,808 | 01 Jan 2026 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CE | Phantom Stock | Conversion of derivative security | $0 | -1,808 | -61% | $0.000000 | 1,141 | 01 Jan 2026 | Common Stock | 1,808 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Each share of phantom stock represents the right to receive one share of Common Stock. |
| F2 | The reported phantom stock represents compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan. |